Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages

Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis using Electrochemiluminescence Immunoassays

(2019) Samantha Stanley et al.   Arthritis & Rheumatology

The immune cell landscape in kidneys of patients with lupus nephritis

(2019) Arnon Arazi et al.   NATURE IMMUNOLOGY

Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices

(2018) Ingeborg M. Bajema et al.   KIDNEY INTERNATIONAL

Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions

(2018) B Obrișcă et al.   LUPUS

Therapy for Proliferative Lupus Nephritis

(2018) Kristin Meliambro et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

An Update on Therapies for Proliferative Lupus Nephritis: How Certain Can We Be About the Evidence?

(2018) Andrew S. Bomback   AMERICAN JOURNAL OF KIDNEY DISEASES

Significance of M2 macrophages in glomerulonephritis with crescents

(2017) Jun Li et al.   PATHOLOGY RESEARCH AND PRACTICE

Renal Macrophages and Dendritic Cells in SLE Nephritis

(2017) Naomi I. Maria et al.   Current Rheumatology Reports

The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function

(2017) Nynke M. Kannegieter et al.   PLoS One

Soluble CD163: A Novel Biomarker with Diagnostic and Therapeutic Implications in Autoimmune Diseases

(2016) D. ZHOU et al.   JOURNAL OF RHEUMATOLOGY

The development and maintenance of resident macrophages

(2016) Elisa Gomez Perdiguero et al.   NATURE IMMUNOLOGY

Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis

(2016) Nobuhide Endo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Systemic lupus erythematosus biomarkers: the challenging quest

(2016) Cristina Arriens et al.   RHEUMATOLOGY

Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis

(2015) Jun Li et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus

(2015) Feng Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis

(2015) Chandra Mohan et al.   Nature Reviews Nephrology

Circulating classical CD14++CD16− monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163

(2015) IZABELA LAPUC et al.   ONCOLOGY REPORTS

M2 Macrophage Infiltrates in the Early Stages of ANCA-Associated Pauci-Immune Necrotizing GN

(2014) L. Zhao et al.   Clinical Journal of the American Society of Nephrology

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

(2014) Peter J. Murray et al.   IMMUNITY

Anti-C1q antibodies in systemic lupus erythematosus

(2014) A-M Orbai et al.   LUPUS

Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes

(2013) Daigo Hashimoto et al.   IMMUNITY

Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

(2013) Gaetano Zizzo et al.   ARTHRITIS RESEARCH & THERAPY

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Glucocorticoids Enhance CD163 Expression in Placental Hofbauer Cells

(2012) Zhonghua Tang et al.   ENDOCRINOLOGY

Efficient Clearance of Early Apoptotic Cells by Human Macrophages Requires M2c Polarization and MerTK Induction

(2012) G. Zizzo et al.   JOURNAL OF IMMUNOLOGY

Soluble CD163

(2011) Holger J. Møller   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host

(2010) Z S Guo et al.   GENE THERAPY

Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy

(2010) Hanne Van Gorp et al.   MOLECULAR IMMUNOLOGY

Treatment of proliferative lupus nephritis: a slowly changing landscape

(2010) Vladimir Tesar et al.   Nature Reviews Nephrology

Soluble macrophage-derived CD163: A homogenous ectodomain protein with a dissociable haptoglobin–hemoglobin binding

(2009) Holger Jon Møller et al.   IMMUNOBIOLOGY